Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Surufatinib
Gemcitabine
+3 more
Locations
1
China
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Start Date
August 15, 2024
Primary Completion Date
December 1, 2025
Completion Date
July 1, 2027
Last Updated
November 27, 2024
NCT04172402
NCT05009953
NCT05823987
NCT04217954
NCT04211168
NCT03358849
Lead Sponsor
Dai, Guanghai
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions